• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法后视网膜中一氧化氮和丙二醛的水平。

Retinal nitric oxide and malonyldialdehyde levels following photodynamic therapy.

机构信息

Department of Ophthalmology, Firat University School of Medicine, Elazig, Turkey.

出版信息

Indian J Ophthalmol. 2011 Jan-Feb;59(1):5-8. doi: 10.4103/0301-4738.73705.

DOI:10.4103/0301-4738.73705
PMID:21157064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3032244/
Abstract

BACKGROUND

To determine the retinal nitric oxide (NO) and malonyldialdehyde (MDA) levels following photodynamic therapy (PDT).

MATERIALS AND METHODS

Seven Dutch-belted rabbits received dextrose, while seven others received 2 mg/kg verteporfin infusion over a period of 15 minutes in a dim-lit room. Irradiation to a 1.5 mm diameter intact chorioretinal area in the right eye of verteporfin-infused rabbits, was started 5 minutes after the end of infusion. Three groups were control (dextrose infusion), infusion with verteporfin (left eyes were not irradiated), and irradiation after verteporfin injection (right eyes were irradiated). On the fifth day of the experiment, the eyes were enucleated. The retinas were subsequently frozen and homogenized. Nitrite, a stable end-product of NO and MDA, was measured using the spectrophotometer. Protein concentrations were measured by the Lowry method. Tissue NO and MDA levels were expressed as μmol/gprt and nmol/mgprt, respectively.

RESULTS

The mean retinal NO and MDA levels of the control, infusion, and irradiation groups were 24.67 ± 6.66, 0.11 ± 0.02; 45.90 ± 15.52, 0.21 ± 0.09; and 84.43 ± 14.96 μmol/gprt, 0.58 ± 0.14 nmol/mgprt, respectively. The mean retinal NO levels were significantly elevated in the infusion and irradiation groups compared with the control group ( p :0.004; p :0.001). The mean retinal MDA levels were significantly elevated in the infusion and irradiation groups compared to the control one ( p :0.026; p :0.001). Also the mean retinal NO and MDA levels in the irradiation group were found to be significantly higher than the infusion group ( p :0.018; p :0.018).

CONCLUSION

Not only PDT, but also verteporfin infusion alone resulted in NO and MDA level increments in the retina, which might be toxic.

摘要

背景

为了确定光动力疗法(PDT)后视网膜的一氧化氮(NO)和丙二醛(MDA)水平。

材料和方法

7 只荷兰兔给予葡萄糖,另 7 只给予 2mg/kg 维替泊芬静脉输注,在暗光房间内输注 15 分钟。维替泊芬输注结束后 5 分钟开始对右眼进行 1.5mm 直径完整脉络膜视网膜区域的照射。实验第 5 天眼球被摘除。视网膜随后冷冻并匀浆。使用分光光度计测量亚硝酸盐,其为 NO 的稳定终产物和 MDA。蛋白浓度通过 Lowry 法测量。组织中的 NO 和 MDA 水平分别以 μmol/gprt 和 nmol/mgprt 表示。

结果

对照组、输注组和照射组的视网膜平均 NO 和 MDA 水平分别为 24.67 ± 6.66、0.11 ± 0.02μmol/gprt;45.90 ± 15.52、0.21 ± 0.09μmol/gprt;84.43 ± 14.96μmol/gprt、0.58 ± 0.14nmol/mgprt。与对照组相比,输注组和照射组的视网膜平均 NO 水平显著升高(p:0.004;p:0.001)。与对照组相比,输注组和照射组的视网膜平均 MDA 水平显著升高(p:0.026;p:0.001)。照射组的视网膜 NO 和 MDA 水平也明显高于输注组(p:0.018;p:0.018)。

结论

不仅 PDT,单独的维替泊芬输注也会导致视网膜中 NO 和 MDA 水平升高,这可能是有毒的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82e/3032244/1121c5e6c343/IJO-59-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82e/3032244/7b2617899117/IJO-59-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82e/3032244/1121c5e6c343/IJO-59-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82e/3032244/7b2617899117/IJO-59-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82e/3032244/1121c5e6c343/IJO-59-5-g002.jpg

相似文献

1
Retinal nitric oxide and malonyldialdehyde levels following photodynamic therapy.光动力疗法后视网膜中一氧化氮和丙二醛的水平。
Indian J Ophthalmol. 2011 Jan-Feb;59(1):5-8. doi: 10.4103/0301-4738.73705.
2
The protective role of Visudyne eyeglass against VEGF synthesis after photodynamic therapy with verteporfin.维速达尔眼镜在维替泊芬光动力疗法后对 VEGF 合成的保护作用。
Acta Ophthalmol. 2009 Nov;87(8):871-4. doi: 10.1111/j.1755-3768.2008.01368.x.
3
Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.新型光敏剂Stakel(WST - 11)用于兔眼和大鼠眼光动力脉络膜血管闭塞的评估。
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767.
4
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.通过将靶向维替泊芬递送至由归巢肽介导至血管内皮生长因子受体-2的实验性脉络膜新生血管来进行选择性光动力疗法。
Arch Ophthalmol. 2004 Jul;122(7):1002-11. doi: 10.1001/archopht.122.7.1002.
5
Contact transscleral ciliary body photodynamic therapy in pigmented rabbits using verteporfin and diode laser: evaluation of treatment parameters.使用维替泊芬和二极管激光对色素兔进行经巩膜睫状体接触式光动力疗法:治疗参数评估
Curr Eye Res. 2006 Jul-Aug;31(7-8):577-85. doi: 10.1080/02713680600788189.
6
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.半剂量维替泊芬光动力疗法治疗急性中心性浆液性脉络膜视网膜病变:一项随机对照试验的一年结果
Ophthalmology. 2008 Oct;115(10):1756-65. doi: 10.1016/j.ophtha.2008.04.014. Epub 2008 Jun 5.
7
Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.玻璃体内注射雷珠单抗联合维替泊芬光动力疗法对正常灵长类动物视网膜和脉络膜的影响。
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):357-63. doi: 10.1167/iovs.04-0087.
8
Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.维替泊芬光动力疗法对食蟹猴正常视网膜和脉络膜的再治疗
Ophthalmology. 1999 Oct;106(10):1915-23. doi: 10.1016/S0161-6420(99)90401-3.
9
Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.在兔角膜新生血管模型中使用维替泊芬进行光动力疗法。
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2954-8. doi: 10.1167/iovs.02-0572.
10
Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.使用维替泊芬的光动力疗法对治疗后长达7周的实验性脉络膜新生血管以及正常视网膜和脉络膜的影响。
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2322-31.

引用本文的文献

1
Light-Activated Pharmaceuticals: Mechanisms and Detection.光激活药物:作用机制与检测
Isr J Chem. 2012 Sep 1;52(8-9):674-680. doi: 10.1002/ijch.201100059.

本文引用的文献

1
Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.在脉络膜新生血管模型中,通过一氧化氮合酶阻断减少光动力疗法后的光感受器损伤。
Invest Ophthalmol Vis Sci. 2007 May;48(5):2268-77. doi: 10.1167/iovs.06-0979.
2
The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells.一氧化氮在δ-氨基乙酰丙酸(ALA)诱导癌细胞光敏感性中的作用。
Biochem Biophys Res Commun. 2007 Feb 16;353(3):541-6. doi: 10.1016/j.bbrc.2006.12.007. Epub 2006 Dec 22.
3
Levels of lipid peroxidation in A549 cells after PDT in vitro.
体外光动力疗法后A549细胞中的脂质过氧化水平。
Rocz Akad Med Bialymst. 2004;49 Suppl 1:82-4.
4
Photodynamic therapy of age-related macular degeneration: History and principles.年龄相关性黄斑变性的光动力疗法:历史与原理
Semin Ophthalmol. 2001 Dec;16(4):181-200. doi: 10.1076/soph.16.4.181.10299.
5
BDNF reduces the retinal toxicity of verteporfin photodynamic therapy.脑源性神经营养因子可降低维替泊芬光动力疗法的视网膜毒性。
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4190-6. doi: 10.1167/iovs.04-0676.
6
Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs.
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3787-95. doi: 10.1167/iovs.04-0147.
7
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
8
Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.金丝桃素介导的光动力疗法可诱导鼻咽癌发生脂质过氧化和坏死。
Int J Oncol. 2003 Nov;23(5):1401-5.
9
Nitric oxide mediated photo-induced cell death in human malignant cells.一氧化氮介导的人类恶性细胞光诱导细胞死亡。
Int J Oncol. 2003 Apr;22(4):751-6.
10
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.维替泊芬治疗年龄相关性黄斑变性患者的黄斑中心凹下脉络膜新生血管:关于基线病变组成对视力结果影响的补充信息——TAP报告第3号
Arch Ophthalmol. 2002 Nov;120(11):1443-54. doi: 10.1001/archopht.120.11.1443.